Mild nausea that improves after a day or two is different from nausea that gets worse, lasts all week, or leads to vomiting
According to the FDA's press release it agreed to approve the drug for obesity based on three randomised, double-blind, placebo-controlled trials during which more than 2,600 patients received Wegovy for up to 68 weeks and more than 1,500 patients received placebo (US FDA 2021)
And when it works, it works well
Association between glucagon-like Peptide-1 receptor agonists exposure and intraocular pressure change: GLP-1 receptor agonists and intraocular pressure change
The ultimate cost to the federal government of the Medicare GLP-1 Bridge will depend on actual participation numbers and adherence during the 18-month program, as well as potential cost offsets from savings that might accrue over time due to beneficiary health improvements from GLP-1 use for weight reduction and weight management
The mechanism behind that survival, for many independents, has shifted from insurance-network participation toward cash-price competitiveness discount programs, direct partnerships with cash-pay platforms, and membership or subscription pricing that doesn't depend on being in a PBM's preferred network at all